Ajanta Pharma has reported results for third quarter ended December 31, 2018.
The company has reported a fall of 42% in its net profit at Rs 95.47 crore for the quarter under review as compared to Rs 164.59 crore for the same quarter in the previous year. Total income of the company decreased by 17.80% at Rs 464.82 crore for Q3FY19 as compared Rs 565.47 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a fall of 54.63% in its net profit at Rs 66.90 crore for the quarter under review as compared to Rs 147.47 crore for the same quarter in the previous year. Total income of the company decreased by 18.71% at Rs 489.52 crore for Q3FY19 as compared Rs 602.20 crore for the corresponding quarter previous year.
